0009K0 — Aimed Bio Balance Sheet
0.000.00%
- KR₩4tn
- KR₩3tn
- KR₩47bn
Annual balance sheet for Aimed Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Short Term Investments | |||
| Cash and Short Term Investments | 18,081 | 35,519 | 170,828 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 674 | 707 | 7,401 |
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 18,809 | 36,227 | 178,523 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 2,353 | 1,469 | 2,104 |
| Net Intangible Assets | |||
| Long Term Investments | |||
| Other Long Term Assets | |||
| Total Assets | 22,432 | 47,141 | 198,969 |
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 15,315 | 43,578 | 5,679 |
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Minority Interest | |||
| Total Other Liabilities | |||
| Total Liabilities | 15,738 | 43,781 | 6,400 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| ESOP Debt Guarantee | |||
| Unrealized Gain / Loss | |||
| Other Equity | |||
| Total Equity | 6,694 | 3,360 | 192,569 |
| Total Liabilities & Shareholders' Equity | 22,432 | 47,141 | 198,969 |
| Total Common Shares Outstanding |